Koningin Wilhelmina Fonds   Report issue

Foundation Phase 3
Founded: Amsterdam Netherlands (1949)

Organization Overview

First Clinical Trial
2003
NCT00312000
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Alternative names

Koningin Wilhelmina Fonds

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colorectal Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 5